Corvus Pharmaceuticals is a company that develops immuno-oncology therapies with the aim to commercialize its products. Its lead product candidate is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also has preclinical stage products in its pipeline and a strategic collaboration with Angel Pharmaceuticals.